Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection?

Autoimmunity Reviews

Volumn 8, Issue 5, 2009, Pages 384-387

  Gleicher, Norbert ^a,b   Elkayam, Uri ^c  

^a Foundation for Reproductive Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Medicine   (United States)

Author keywords

Allograft; Autoimmunity; Graft versus host disease (GVHD); Peripartum cardiomyopathy; Pregnancy; Rejection

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CARDIOMYOPATHY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; PREGNANCY; REVIEW;

ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIGENS; AUTOIMMUNITY; CARDIAC MYOSINS; CARDIOMYOPATHIES; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMANS; ORGAN SPECIFICITY; PLACENTAL CIRCULATION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 61549139016     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.12.003     Document Type: Review

References (40)

1. Gouley B.A., McMillan T.M., and Bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially in the peripartum. Am J Med Sci 19 (1937) 185-199
2. Demakis J.G., Rahimtoola S.H., Sutton G.C., Meadows W.R., Szabo P.B., Tobin J.R., et al. Natural course of peripartum cardiomyopathy. Circulation 44 (1971) 1053-1061
3. Sliwa K., Fett J., and Elkayam U. Peripartum cardiomyopathy. Lancet 368 (2006) 687-693
4. Abboud J., Murad Y., Chen-Scarabelli C., Saravolatz L., and Scarabelli T.M. Postpartum cardiomyopathy: a comprehensive review. Int J Cardiol 118 (2007) 295-303
5. Elkayam U., Akhter M.W., Singh H., Khan S., Bitar F., Hameed A., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentations. Circulation 111 (2005) 2050-2055
6. Yang D.H., Lee S.H., Goo T.B., Park H.S., Cho Y., Chae S.C., et al. N-terminal pro-natriuretic peptide in patients with preeclampsia. J Am Coll Cardiol 51 (2008) A337
7. Gleicher N. Postpartum depression, an autoimmune disease?. Autoimmun Rev 6 (2007) 572-576
8. Ansari A.A., Fett J.D., Carraway R.E., Mayne A.E., Onlamoon N., and Sundstrom J.B. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 23 (2002) 301-324
9. Sundstrom J.B., Fett J.D., Carraway R.D., and Ansari A.A. Is peripartum cardiomyopathy an organ-specific autoimmune disease?. Autoimmun Rev 1 (2002) 73-77
10. Fennira S., Demiraj A., Khouaja A., and Boujnah M.R. Peripartum cardiomyopathy. Ann Cardiol Angeiol (Paris) 55 (2006) 271-275
11. Lamparter S., Pankuweit S., and Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol 118 (2007) 14-20
12. Gleicher N. Why much of the pathophysiology of preeclampsia-eclampsia has to be autoimmune in nature. Am J Obstet Gynecol 196 (2007) 5.e1-5.e7
13. Gleicher N. Graft-versus host disease and immunologic rejection: implications for diagnosis and treatments of pregnancy complications. Expert Rev Obstet Gynecol 3 (2008) 37-49
14. Gleicher N. Pregnancy-related cell traffic, microchimerism and autoimmunity: the possibility of reducing autoimmune disease prevalence. Expert Rev Obstet Gynecol 2 (2007) 341-345
15. Nelson J.L., Hughes K.A., Smith A.G., Nisperos B.B., Branchaud A.M., and Hansen J.A. Maternal-fetal disparity in HLA claa II alloantigens and pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 329 (1993) 466-471
16. Davies T.F. The thyroid immunology of the postpartum period. Thyroid 9 (1999) 675-684
17. Ruiz-Irastorza G., Lima F., Alves J., Khamashta M.A., Simpson J., Hughes G.R., et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 35 (1996) 133-138
18. Platzbecker U., Klingel K., Thiede C., Freiberg-Richter J., Schuh D., Ehninger G., et al. Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin. Bone Marrow Transplant 27 (2001) 107-109
19. Warraich R.S., Pomerance A., Stanley A., Banner N.R., Dunn M.J., and Yacoub M.H. Cardiac myosis autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy. Transplantation 27 (2000) 1609-1617
20. Morgun A., Shulzhenko N., Unterkircher C.S., Diniz R.V., Pereira A.B., Silvas M.S., et al. Pre- and post-transplant anti-myosis anti-heat shock protein antibodies and cardiac transplant outcome. J Heart Lung Transplant 23 (2004) 204-209
21. Ferry B.L., Welsh K.I., Dunn M.J., Law D., Proctor J., Chapel H., et al. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection. Transpl Immunol 5 (1997) 17-24
22. Lauer B., Schannwell M., Kühl U., Strauer B.E., and Schultheiss H.P. Anitmyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 35 (2000) 11-18
23. Kishimoto C., Sioji K., Kinoshita M., Iwase T., Tamaki S., Fujii M., et al. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int J Cardiol 91 (2003) 173-178
24. Latif N., Baker C.S., Dunn M.J., Rose M.L., Brady P., and Yacoub M.H. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. Am J Cardiol 22 (1993) 1378-1384
25. Warraich R.S., Dunn M.J., and Yacoub M.H. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients. Biochem Biophys Res Commun 259 (1999) 255-261
26. Warraich R.S., Noutsias M., Kazak I., Seeberg B., Dunn M.J., Schultheiss H.P., et al. Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates. Am Heart J 143 (2002) 1076-1084 [Erratum, Am Heart J 2003; 145: 213]
27. Bahrmann P., Hengst U.M., Richartz B.M., and Figulla H.R. Pentoxifylline in ischemic, hypertensive and idiopathic dilated cadiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms. Eur J Heart Fail 6 (2004) 195-201
28. Tatli E., and Kurum T. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Can J Cardiol 21 (2005) 344-348
29. Caforio A.L., Tona F., Bottaro S., Vinci A., Dequal G., Daliento L., et al. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 41 (2008) 35-45
30. Sliwa K., Woodiwiss A., Candy G., Badenhorst D., Libhaber C., Norton G., et al. Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 90 (2002) 1118-1122
31. Sliwa K., Skudicky D., Candy G., Bergemann A., Hopley M., and Sareli P. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 4 (2002) 305-309
32. Gleicher N., Weghofer A., and Barad D. Female infertility due to abnormal autoimmunity: frequently overlooked and greatly underappreciated. Part I. Expert Rev Obstet Gynecol 2 (2007) 453-464
33. Goland S., Bitar F., Modi K., Akter M.W., Janmohamed M., Hatamizadeh P., et al. Clinical profile and risk predictors of major adverse events in patients with peripartum cardiomyopathy. Circulation 114 (2006) II-622
34. Edwards C.J., and Hughes G.R. Hughes syndrome (the antiphospholipid syndrome): 25 years old. Mod Rheumatol 18 (2008) 119-124
35. Hilfiker-Kleiner D., Kaminski K., Podewski E., Bonda D., Schaefer A., Sliwa K., et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128 (2007) 589-600
36. Hilfiker-Kleiner D., Meyer G.P., Schieffer E., Goldmann B., Podewski E., Struman I., et al. J Am Coll Cardiol 11 50 (2007) 2354-2355
37. Vera-Lastra O., Jara L.J., and Espinoza L.R. Prolactin and autoimmunity. Autoimmune Rev 1 (2002) 360-364
38. Orbacj H., and Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmune Rev 6 (2007) 537-542
39. Peeva E., Venkatesh J., Michael D., and Diamond B. Prolactin as a modulator of B cell function: Implications for SLE. Biomed Pharmacother 58 (2004) 310-319
40. Lampert M.B., Weinert L., Hibbard J., Korcarz C., Lindheimer M., and Lang R.M. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function dysfunction. Am J Obstet Gynecol 176 (1997) 189-195